Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

42
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Stages of Infection01:26

Stages of Infection

70.2K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
70.2K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Survey on Genetic Literacy and Awareness in Patients With Spinal and Bulbar Muscular Atrophy.

Neurology. Genetics·2026
Same author

Potential Consequences of Codeine Use in Lactating Mothers.

Hospital pharmacy·2024
Same author

Fibromyalgia: Diagnosis and Management.

American family physician·2023
Same author

Pancreatic Adenocarcinoma in New Mexico Native Americans: Disparities in Treatment and Survival.

Journal of health care for the poor and underserved·2019
Same author

5 drug interactions you don't want to miss.

The Journal of family practice·2017
Same author

Authors' reply.

Annals of gastroenterology·2017

Related Experiment Video

Updated: May 1, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.2K

Common questions about Clostridium difficile infection.

Bradford T Winslow1, Mary Onysko2, Kathleen A Thompson3

  • 1Swedish Family Medicine Residency Program, Littleton, CO, USA.

American Family Physician
|April 4, 2014
PubMed
Summary
This summary is machine-generated.

Clostridium difficile infection (CDI) is a growing concern, often linked to antibiotic use. Treatment varies by severity, with prevention focusing on responsible antibiotic prescribing and hygiene.

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

8.4K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

9.3K

Related Experiment Videos

Last Updated: May 1, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.2K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

8.4K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

9.3K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • Clostridium difficile infection (CDI) is a significant cause of antibiotic-associated diarrhea, with increasing incidence and severity.
  • Risk factors include antibiotic exposure, older age, hospitalization, comorbidities, gastric acid blockers, inflammatory bowel disease, and immunosuppression.
  • CDI is increasingly prevalent in younger, healthier individuals in community settings.

Purpose of the Study:

  • To review the epidemiology, risk factors, diagnosis, treatment, and prevention of Clostridium difficile infection.
  • To provide an overview of current management strategies for CDI.
  • To highlight emerging trends in CDI, including its occurrence in non-traditional patient populations.

Main Methods:

  • Literature review of studies on Clostridium difficile infection.
  • Analysis of risk factors, diagnostic methods, and treatment guidelines.
  • Evaluation of prevention strategies, including antibiotic stewardship and hygiene.

Main Results:

  • Antibiotic exposure is the primary modifiable risk factor for CDI.
  • Rapid diagnostic tests (NAA or EIA) and two-step strategies are practical options.
  • Treatment recommendations include metronidazole for mild CDI, vancomycin for severe CDI, and fidaxomicin as an alternative.
  • Tapering and pulsed-dose vancomycin are effective for recurrent CDI.
  • Probiotics may prevent antibiotic-associated diarrhea but are not specifically recommended for CDI prevention.

Conclusions:

  • Effective management of Clostridium difficile infection requires careful consideration of risk factors and appropriate treatment based on severity.
  • Recurrence prevention strategies, such as specific vancomycin dosing regimens, are crucial.
  • Responsible antibiotic prescribing and hand hygiene are key preventive measures against CDI.